El Rouby, Nihal
,
McDonough, Caitrin W.
Gong, Yan
McClure, Leslie A.
Mitchell, Braxton D.
Horenstein, Richard B.
Talbert, Robert L.
Crawford, Dana C.
Gitzendanner, Matthew A.
Takahashi, Atsushi
Tanaka, Toshihiro http://orcid.org/0000-0001-6201-9784
Kubo, Michiaki
Pepine, Carl J. http://orcid.org/0000-0002-6011-681X
Cooper-DeHoff, Rhonda M.
Benavente, Oscar R.
Shuldiner, Alan R.
Johnson, Julie A.
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (U01-GM074492, NIH R01 HL074730, R01 NS073346, U01GM074492-05S109, 1 KL2 TR001429, U01HG04603, U01HG006378)
INVEST was supported by grants from the University of Florida Opportunity Fund and Abbott Pharmaceuticals
Article History
Received: 11 August 2017
Revised: 2 August 2018
Accepted: 10 August 2018
First Online: 20 September 2018
Compliance with ethical standards
:
: Dr. Shuldiner is employed by Regeneron Pharmaceuticals, Inc. The remaining authors declare that they have no conflict of interest.